Clinical trial
Protective Effect of EPA on Cardiovascular Events
NCT00231738 · Kobe University, Industry · Completed
Key facts
| NCT number | NCT00231738 |
|---|---|
| Title | Protective Effect of EPA on Cardiovascular Events |
| Official title | Effect of Eicosapentaenoic Acid (EPA) on Major Cardiovascular Events in Hypercholesterolemic Patients: the Japan EPA Lipid Intervention Study (JELIS) |
| Lead sponsor | Kobe University, Industry |
| Collaborators | Mochida Pharmaceutical Company, Ltd. Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Myocardial Infarction, Unstable Angina Pectoris, Sudden Cardiac Death, Stroke, Peripheral Artery Disease |
| Intervention type | Drug |
| Interventions | Eicosapentaenoic acid ethyl ester(EPADEL Capsule 300 TM) |
| Enrollment | 18,000 |
| Start date | Nov 1, 1996 |
| Completion | Nov 1, 2004 |
| First posted | Oct 4, 2005 |
| Last update posted | Nov 20, 2015 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: